Dexcom Inc. buy Wells Fargo & Company
Start price
11.12.24
/
50%
€77.00
Target price
11.12.25
€89.52
Performance (%)
-23.95%
End price
12.12.25
€58.56
Summary
This prediction ended on 12.12.25 with a price of €58.56. The price of Dexcom Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.95%. Wells_Fargo___Compan has a follow-up prediction for Dexcom Inc. where he still thinks Dexcom Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dexcom Inc. | -6.165% | -6.165% | -13.924% |
| iShares Core DAX® | 0.751% | -8.496% | 2.575% |
| iShares Nasdaq 100 | -1.405% | -2.771% | 15.682% |
| iShares Nikkei 225® | 0.417% | -9.291% | 29.655% |
| iShares S&P 500 | -0.590% | -2.868% | 9.963% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Dexcom Inc. diskutieren
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Wells Fargo & Company from $90.00 to $94.00. They now have an "overweight" rating on the stock.
Ratings data for DXCM provided by MarketBeat
In the thread Trading Dexcom Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten

